This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Université Pierre Et Marie Curie (Paris 6), Universitéde Liége. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015-2017
Title: Alain Hovnanian: Innovator in Pharmaceutical Sciences
Introduction
Alain Hovnanian, based in Vincennes, France, is a notable inventor with a focus on pharmaceutical innovations. With three patents to his name, he has made significant contributions to the field of medicine, specifically targeting skin diseases.
Latest Patents
Among his latest innovations is the patent related to the "Use of coumarin derivatives for the preparation of drugs for treating skin diseases." This patent details a compound of formula (I-1), involving various groups such as hydrogen, C1-C7 alkyl, and specific components aimed at treating pathologies involving excess activity from the kallikrein family. This groundbreaking work underlines the potential of coumarin derivatives in therapeutic applications.
Career Highlights
Alain Hovnanian has had a distinguished career, significantly shaped by his tenure at reputable institutions. He has worked at Université Pierre et Marie Curie (Paris 6) and Université de Liège, contributing his expertise in pharmaceutical sciences and advancing research in drug development.
Collaborations
Throughout his career, Alain has collaborated with esteemed colleagues in the field. Notable among them are Michele Reboud-Ravaux and Chahrazade Yerroum-El Amri. These collaborations have played a vital role in enhancing the quality and impact of his research.
Conclusion
Alain Hovnanian's work exemplifies the intersection of innovation and healthcare. With his patents demonstrating practical solutions for pressing medical issues, he continues to be an influential figure in the realm of pharmaceutical inventions. His contributions reflect a dedication to improving patient outcomes and advancing the science of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile